FLNA:BMV
Filana Therapeutics Inc
28,00 MX$
0,00%
(0,00) 1 d
29 apr., 12:17:30 GMT−6 · MXN
search
Alla symboler
1 d
5 d
1 m
6 m
Hittills i år
1 år
5 år
MAX
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för FLNA …
Börsvärde
70,05 mn
Genomsn. vol.
13,00
Volym
0,00
52v högst
56,00 MX$
52v lägst
28,00 MX$
Antal anställda
19
Nyheter och artiklar
Från källor på webben
Newser
·
för 1 vecka sedan
FLNA Filana Therapeutics posts narrower than expected Q3 2025 loss, shares edge higher in today’s trading. - Stock Community Signals
Newser
·
för 1 vecka sedan
Is Filana Therapeutics (FLNA) stock appealing for long-term investors (Slight Rise) 2026-04-20 - Buy Zone Stocks
Profil
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. The company was developing simufilam, an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to company, Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. The DOJ dropped the fraud charges against Wang shortly before trial was scheduled to begin in October 2025 without giving a reason. Wikipedia
Om Filana Therapeutics Inc
Vd-
Anställda19
Grundades1998
HuvudkontorAustin, Texas, USA
Sektor-
Webbplats-
AI-innehåll kan innehålla fel. Läs mer